Teleflex stock: buy or sell?

TFX stock price: $366.16 -0.44% At close on August 22nd, 2019

Updated on:
August 22nd, 2019

0

After several days of continuous rises in past weeks, Teleflex decreased -0.44% to $366.16. With Thursday it's been 3 red days in a row.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

Should I buy Teleflex stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, 2 buy setups work for Teleflex stock now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Teleflex stock a buy?

Banks and financial institutions publish stock ratings everyday. At Stocks2.com, we gathered 15 ratings published for TFX stock in the last 30 days.

The general sentiment of these ratings is bullish for TFX stock, with 9 positive ratings.
Is TFX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-5JMP Securitiesn/aOutperform
2019-8-5Barclaysn/aEqual Weight
2019-8-2Raymond Jamesn/aStrong-Buy
2019-8-2Needham & Company LLCBuyBuy
2019-8-2Needham & Company LLCBuyBuy
2019-8-2Morgan Stanleyn/aOverweight
2019-7-16Morgan Stanleyn/aOverweight
2019-6-11Wells Fargo & Con/aOutperform
2019-4-15BarclaysEqual WeightEqual Weight
2019-3-27Raymond JamesStrong-BuyStrong-Buy
2019-3-26Needham & Company LLCn/aBuy
2019-3-22UBS Groupn/aBuy
2019-2-22Needham & Company LLCStrong-BuyStrong-Buy
2019-2-22Needham & Company LLCn/aStrong-Buy
2019-1-2Morgan StanleyOverweightBuy

Teleflex stock analysis

Daily outlook

Teleflex decreased -0.44% to $366.16 after topping to all time highs on August 20th.

After topping to all time highs on August/20, Teleflex decreased -0.44% today to $366.16. On April TFX price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock. On Aug 20th, TFX hit a new all time high, pushing higher than on Monday tops. Check different trading setups that use ATHs as triggers.

TFX stock chart (daily)

Weekly outlook

Teleflex topped new all time highs again this week, marking to $373.90. Shares ended at $366.16 and depreciated -0.99% during the week.

Teleflex stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, TFX might consolidate in a flat-base, waiting to break out over or down under . Since early March when SMA20w and SMA40w crossed up, TFX price gained $72.26 per share (24.59%). Since price and SMA40w lines crossed up late January, TFX climbed $109.08 (42.43%).

TFX stock chart (weekly)

Teleflex stock price history

Teleflex IPO was on March 17th, 1980 at $0.73 per share1. Since then, TFX stock surged a 50,058.90%, with an average of 1,283.60% per year. If you had invested right after TFX's IPO a $1,000 in Teleflex stock in 1980, it would worth $500,589.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Teleflex stock historical price chart

TFX stock reached all-time highs on Aug 20th with a price of $373.90.

Teleflex stock price target is $356.40

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 15 price forecasts for Teleflex stock:
TFX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-5JMP SecuritiesRaises Target$325.00$395.0021.5%
2019-8-5BarclaysRaises Target$309.00$356.0015.2%
2019-8-2Raymond JamesRaises Target$350.00$420.0020%
2019-8-2Needham & Company LLCReiterates$325.00$403.0024%
2019-8-2Needham & Company LLCRaises Target$325.00$403.0024%
2019-8-2Morgan StanleyRaises Target$345.00$392.0013.6%
2019-7-16Morgan StanleyRaises Target$320.00$345.007.8%
2019-6-11Wells Fargo & CoInitiatesn/a$345.00-
2019-4-15BarclaysRaises Target$287.00$309.007.7%
2019-3-27Raymond JamesRaises Target$320.00$348.008.8%
2019-3-26Needham & Company LLCReiteratesn/a$325.00-
2019-3-22UBS GroupRaises Targetn/a$350.00-
2019-2-22Needham & Company LLCReiterates$300.00$325.008.3%
2019-2-22Needham & Company LLCRaises Target$300.00$325.008.3%
2019-1-2Morgan StanleyReiterates$295.00$305.003.4%
(in average)$316.80$356.4013.0%
Moving in a range from $420.00 and $305.00, the price forecast for Teleflex stock is $356.40. In average, analysts' outlook on TFX price forecast is positive, improving the prediction by a 13.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on February, Teleflex . Unfortunately, reported EPS is not yet available in our database.
TFX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a1.68n/a
2017-Q32017-11-0222.126.0%
2017-Q42018-02-222.42.441.7%
2018-Q12018-05-031.942.1510.8%
2018-Q22018-08-022.412.472.5%
2018-Q32018-11-012.412.524.6%
2018-Q42019-02-212.782.77-0.4%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

Compared to 2017, last anual sales report draw an astounding gain of 14.07% to $2,448.38 M USD. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) raised a 1.09% to 8.20%.

TFX annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$1,700 M-$151 M8.9%-
2014$1,840 M8.23%$188 M10.2%24.03%
2015$1,810 M-1.64%$245 M13.5%30.47%
2016$1,868 M3.22%$237 M12.7%-3.06%
2017$2,146 M14.90%$153 M7.1%-35.74%
2018$2,448 M14.07%$201 M8.2%31.65%

Quarterly financial results

Teleflex posted $641.62 million in sales for 2018-Q4, a 5.24% up compared to previous quarter. Reported quarter earnings marked $90.59 M with a profit margin of 14.12%. Profit margin gained a 4.85% compared to previous quarter when profit margin was 9.27%. When comparing turnover to same quarter last year, Teleflex sales marked a pretty good increase and rose a 7.82%.
TFX quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$529 M-$78 M14.8%-
2017-Q3$535 M1.15%$77 M14.4%-1.72%
2017-Q4$595 M11.30%$-43 M-7.2%-155.39%
2018-Q1$587 M-1.32%$56 M9.6%-231.71%
2018-Q2$610 M3.85%$-2 M-0.4%-104.44%
2018-Q3$610 M-0.03%$57 M9.3%-2,364.58%
2018-Q4$642 M5.24%$91 M14.1%60.27%
2019-Q1$614 M-4.37%$41 M6.7%-54.85%

Teleflex ownership

When you are planning to buy a company, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Teleflex, 0.25% of all outstanding shares are owned by its staff.

Bearish positions for TFX stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Teleflex:

TFXABMDANGOBDXBSX
Market cap$16.9 B$8.8 B$706.8 M$68.8 B$59.3 B
Total shares46.2 M45.3 M37.3 M269.7 M1,390.0 M
Float shares46.0 M44.4 M36.8 M269.1 M1,390.0 M
  - Institutional holdings (%)95.2%89.8%102.5%87.5%93.4%
  - Insider holdings (%)0.2%4.1%2.5%0.3%0.2%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

Teleflex summary

Thursday, August 22nd, 2019
Open$369.37
Close$366.16
Day range$361.99 - $369.37
Previous close$367.78
Session gain-0.44%
Average true range$8.16
50d mov avg$344.50
100d mov avg$319.60
200d mov avg$294.60
Daily pattern
Weekly pattern lt06a

Teleflex performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Teleflex, the benchmark is made against ABIOMED, AngioDynamics, Becton, Dickinson and, Boston Scientific, The Cooper Companies, General Electric, Integra LifeSciences, and Merit Medical Systems.
Stock3m6m12m
TFXTeleflex23.98%28.71%48.54%
ABMDABIOMED-27.72%-44.57%-48.71%
ANGOAngioDynamics-1.61%-17.57%-14.75%
BDXBecton, Dickinson...8.85%2.86%1.17%
BSXBoston Scientific10.92%5.31%22.90%
COOThe Cooper Compan...13.27%12.74%26.89%
GEGeneral Electric-13.24%-16.09%-31.00%
IARTIntegra LifeScien...25.65%12.10%3.88%
JNJ-5.27%-2.41%-0.66%
MMSIMerit Medical Sys...-34.37%-41.91%-39.95%

Teleflex competitors

One check before investing in any stock is to have a look a list of its competitors, in this case for Teleflex. We picked 9 companies as Teleflex competitors as they are in the same industry or have similar market objectives.

Latest Teleflex stock news